Crocus sativus by-products as sources of bioactive extracts: Pharmacological and toxicological focus on anthers
Giuseppe Chichiriccò(University of L'Aquila), Giustino Orlando(University of Chieti-Pescara), Sheila Leone(University of Chieti-Pescara), Luigi Menghini(University of Chieti-Pescara), Giulia Vecchiotti(University of L'Aquila), Barbara Lanza(Centro di Ricerca per l’Orticoltura), Annalisa Chiavaroli(University of Chieti-Pescara), Claudio Ferrante(University of Chieti-Pescara), Maurizio Ronci(University of Chieti-Pescara), Lucia Recinella(University of Chieti-Pescara), Pierpaolo Piccone, Luigi Brunetti(University of Chieti-Pescara), Simonetta Cristina Di Simone(University of Chieti-Pescara), Annamaria Poma(University of L'Aquila), Stefania Cesa(Sapienza University of Rome)
Cited by 48
Related Papers
Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
|Frontiers in Physiology|2020|264
Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study
|Molecules|2018|143
Crocus sativus L. stigmas and byproducts: Qualitative fingerprint, antioxidant potentials and enzyme inhibitory activities
|Food Research International|2018|142
Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus
|European Journal of Pharmacology|2002|120
Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
|International Journal of Molecular Sciences|2020|110